Company Filing History:
Years Active: 2024-2025
Title: **Innovative Contributions of Susannah Patarroyo-White in Gene Therapy**
Introduction
Susannah Patarroyo-White, an accomplished inventor based in Waltham, MA, has made significant strides in the field of gene therapy. With a remarkable portfolio featuring two patents, she has demonstrated a strong commitment to innovation, focusing on the treatment of metabolic and bleeding disorders. Her groundbreaking work has the potential to revolutionize therapeutic approaches in this vital area of medicine.
Latest Patents
Susannah's latest patents focus on nucleic acid molecules designed for non-viral gene therapy. The first patent details nucleic acid molecules that include inverted terminal repeats (ITRs) and a genetic cassette encoding a target sequence. This target sequence may encode either a microRNA or a therapeutic protein, including clotting factors and growth factors. The second patent also centers on nucleic acid molecules incorporating ITRs and emphasizes the treatment of bleeding disorders such as hemophilia through the administration of these therapeutic agents. Both patents underscore Susannah's innovative approach to gene therapy, aiming to enhance treatment options for patients with significant medical needs.
Career Highlights
Susannah currently works at Bioverativ Therapeutics Inc., where she collaborates with a talented team to further develop her pioneering concepts in gene therapy. Her career is marked by a dedication to improving patient outcomes through scientific research and innovation, reflecting her steadfast contribution to the medical community.
Collaborations
Throughout her career, Susannah has had the opportunity to work alongside esteemed colleagues such as Alexey Seregin and Tongyao Liu. These collaborations have not only enriched her research but also fostered an environment of collective innovation that drives advancements in the field of gene therapy.
Conclusion
In summary, Susannah Patarroyo-White stands out as a prominent inventor within the medical field, particularly in gene therapy. Her significant patents, along with her collaboration with others in the industry, highlight her role as a key player in developing transformative therapies. With continued dedication to innovation, Susannah is poised to make lasting contributions that could reshape the landscape of how metabolic and bleeding disorders are treated.